Press "Enter" to skip to content

New patent expiration for Galderma Labs drug SOOLANTRA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Galderma Labs drug SOOLANTRA

Annual Drug Patent Expirations for SOOLANTRA
Annual Drug Patent Expirations for SOOLANTRA

Soolantra is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug and one Paragraph IV challenge.

SOOLANTRA drug price trends.

Drug patent litigation for SOOLANTRA.

This drug has sixty-one patent family members in twenty-seven countries.

The generic ingredient in SOOLANTRA is ivermectin. One supplier is listed for this compound. Additional details are available on the ivermectin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Galderma Labs drug SOOLANTRA
    Do NOT follow this link or you will be banned from the site!